Painreform Stock Today
| PRFX Stock | USD 3.02 0.23 7.08% |
Performance8 of 100
| Odds Of DistressLess than 21
|
Painreform is trading at 3.02 as of the 18th of January 2025; that is 7.08 percent decrease since the beginning of the trading day. The stock's open price was 3.25. Painreform has about a 21 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 18th of January 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 1st of September 2020 | Category Healthcare | Classification Health Care |
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel. The company has 874.86 K outstanding shares of which 55.89 K shares are at this time shorted by private and institutional investors with about 0.01 trading days to cover. More on Painreform
Moving against Painreform Stock
Painreform Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO CFO | Ilan MBA | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsPainreform can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Painreform's financial leverage. It provides some insight into what part of Painreform's total assets is financed by creditors.
| |||||
Painreform (PRFX) is traded on NASDAQ Exchange in USA. It is located in 65 Yigal Alon St., Tel Aviv, Israel, 6744316 and employs 7 people. Painreform is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.84 M. Painreform conducts business under Biotechnology sector and is part of Health Care industry. The entity has 874.86 K outstanding shares of which 55.89 K shares are at this time shorted by private and institutional investors with about 0.01 trading days to cover.
Painreform currently holds about 13.85 M in cash with (6.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.3.
Check Painreform Probability Of Bankruptcy
Ownership AllocationRoughly 91.74 pct. of Painreform outstanding shares are held by general public with 1.69 % owned by insiders and only 6.57 (%) by third-party entities.
Check Painreform Ownership Details
Painreform Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Ubs Group Ag | 2024-09-30 | 26 K | |
| Two Sigma Securities, Llc | 2024-09-30 | 17.2 K | |
| Hrt Financial Llc | 2024-09-30 | 14.3 K | |
| Advisor Group Holdings, Inc. | 2024-09-30 | 768 | |
| Armistice Capital, Llc | 2024-09-30 | 0.0 | |
| Virtu Financial Llc | 2024-09-30 | 0.0 |
Painreform Historical Income Statement
Painreform Stock Against Markets
Painreform Corporate Management
| Sigal Aviel | Chief Officer | Profile | |
| Rita Keynan | Vice Operations | Profile | |
| Eyal Broder | Interim Officer | Profile | |
| MBA MBA | CEO CFO | Profile | |
| Pr Hazum | CTO Director | Profile |
Additional Tools for Painreform Stock Analysis
When running Painreform's price analysis, check to measure Painreform's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Painreform is operating at the current time. Most of Painreform's value examination focuses on studying past and present price action to predict the probability of Painreform's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Painreform's price. Additionally, you may evaluate how the addition of Painreform to your portfolios can decrease your overall portfolio volatility.